4202001
PRONOVA® SLG 20
sodium alginate solution, Mw 75-150 kDa, guluronate monomer units ≥60 %
Synonym(s):
Sterile sodium alginate, Alginate / Alginic acid
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.25
UNSPSC Code:
12352201
Quality Level
sterility
sterile (Total viable count (CFU/g))
form
powder
mol wt
Mw 75-150 kDa
composition
guluronate monomer units, ≥60% , G/M ratio, ≥1.5
pH
5.5-8.5 (20 °C, 1% in water)
viscosity
20-99 mPa.s, 1 % in water(20 °C)
General description
SLG-20 is made from an alginate where over 60% of the monomer units are guluronate and is a highly purified and well-characterized sodium alginate. The molecular weight for PRONOVA SLG-20 is in the 75000 – 220000 g/mol range. The ultra low levels of endotoxins, proteins and product sterility allows for a big variety of in vitro and in vivo applications.
Application
Examples of Pronova Alginates applications include: encapsulation of living cells and therapeutic proteins for cell therapy medications, cryoprotectant, bone putty binder for tissue engineering, 3D bioprinting, foams and cell tissue scaffolds, hydrogels, advanced drug delivery and implants, wound management, and medical devices.
Legal Information
Product of Dupont Nutrition USA, Inc.
PRONOVA is a registered trademark of International N&H USA, Inc.
Disclaimer
NOT FOR USE IN HUMANS
Storage Class
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 4202001-250MG | 04065267988238 |